BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34937878)

  • 1. MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers.
    Desi N; Teh V; Tong QY; Lim CY; Tabatabaeian H; Chew XH; Sanchez-Mejias A; Chan JJ; Zhang B; Pitcheshwar P; Siew BE; Wang S; Lee KC; Chong CS; Cheong WK; Lieske B; Tan IJ; Tan KK; Tay Y
    Oncogene; 2022 Feb; 41(8):1178-1189. PubMed ID: 34937878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
    Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
    Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma.
    Wang L; Zhang X; Jia LT; Hu SJ; Zhao J; Yang JD; Wen WH; Wang Z; Wang T; Zhao J; Wang RA; Meng YL; Nie YZ; Dou KF; Chen SY; Yao LB; Fan DM; Zhang R; Yang AG
    Hepatology; 2014 May; 59(5):1850-63. PubMed ID: 24002871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
    Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
    Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer cells expressing a shortened CDK16 3'UTR escape senescence through impaired miR-485-5p targeting.
    Jia Q; Xie B; Zhao Z; Huang L; Wei G; Ni T
    Mol Oncol; 2022 Mar; 16(6):1347-1364. PubMed ID: 34687270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.
    Yan X; Zhu Z; Xu S; Yang LN; Liao XH; Zheng M; Yang D; Wang J; Chen D; Wang L; Liu X; Liu J; Chen RH; Zhou XZ; Lu KP; Liu H
    Sci Rep; 2017 Apr; 7():45915. PubMed ID: 28383568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.
    Komoll RM; Hu Q; Olarewaju O; von Döhlen L; Yuan Q; Xie Y; Tsay HC; Daon J; Qin R; Manns MP; Sharma AD; Goga A; Ott M; Balakrishnan A
    J Hepatol; 2021 Jan; 74(1):122-134. PubMed ID: 32738449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
    Zhang JF
    Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of versican 3'-untranslated region modulates endogenous microRNA functions.
    Lee DY; Jeyapalan Z; Fang L; Yang J; Zhang Y; Yee AY; Li M; Du WW; Shatseva T; Yang BB
    PLoS One; 2010 Oct; 5(10):e13599. PubMed ID: 21049042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
    Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
    BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-binding protein RBM38 inhibits colorectal cancer progression by partly and competitively binding to PTEN 3'UTR with miR-92a-3p.
    Guan B; Li G; Wan B; Guo X; Huang D; Ma J; Gong P; Guo J; Bu Y
    Environ Toxicol; 2021 Dec; 36(12):2436-2447. PubMed ID: 34453780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.
    Zhang X; Zhang X; Wang T; Wang L; Tan Z; Wei W; Yan B; Zhao J; Wu K; Yang A; Zhang R; Jia L
    Cancer Lett; 2018 Jul; 426():98-108. PubMed ID: 29653269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).
    Dhanasekaran R; Gabay-Ryan M; Baylot V; Lai I; Mosley A; Huang X; Zabludoff S; Li J; Kaimal V; Karmali P; Felsher DW
    Oncotarget; 2018 Jan; 9(5):5517-5528. PubMed ID: 29464015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
    Buechner J; Tømte E; Haug BH; Henriksen JR; Løkke C; Flægstad T; Einvik C
    Br J Cancer; 2011 Jul; 105(2):296-303. PubMed ID: 21654684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.
    Wang Y; Cui M; Sun BD; Liu FB; Zhang XD; Ye LH
    Acta Pharmacol Sin; 2014 Sep; 35(9):1207-14. PubMed ID: 25087998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
    Shen G; Lin Y; Yang X; Zhang J; Xu Z; Jia H
    BMC Cancer; 2014 Jun; 14():393. PubMed ID: 24890815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.